NeuroMetrix Reiterates Its Evaluation of Strategic Alternatives

WOBURN, Mass., Aug. 13, 2024 (GLOBE NEWSWIRE) — NeuroMetrix, Inc. (Nasdaq: NURO) today reiterated, for clarity, that the company is conducting an evaluation of strategic alternatives.

In February of this year, the company announced that it had initiated a review of strategic options with the aim of enhancing shareholder value. Over the past 6 months, the company has invested significant effort in evaluating a number of specific strategic directions and making financial, operational and commercial optimizations.